Stay updated on Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial page.

Latest updates to the Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial page
- Check2 days agoChange DetectedThe page’s footer revision/version was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page now shows Revision: v3.4.3 and no longer shows Revision: v3.4.2.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded Revision: v3.4.2 and removed the older Notice about government funding lapses and operating status (Revision: v3.4.1).SummaryDifference0.3%

- Check81 days agoChange DetectedAdded a funding-status notice about potential data-outdatedness due to a government funding lapse and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

Stay in the know with updates to Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial page.